TiUnite
1 /2Pages

TiUnite

TiUnite
1 /2Pages

Catalog excerpts

TiUnite-1

Setting the scientific standard. Again. The largest meta-analysis of a single implant brand unequivocally shows that the TiUnite implant surface supports peri-implant health, bone maintenance and overall treatment success, long term. Excellent implant survival rates, short- and long-term Good bone maintenance -1 mm Marginal bone level change from implant insertion at 5-year follow-up * Results of regression analysis. Details can be found in full publication. † Of 106 studies, 47 reported biological complications. Of these 47 papers, 19 reported cases of peri-implantitis in 5.2% of patients (64/1229). The authors postulated that, if peri-implantitis did not occur in studies where it was not explicitly reported, its prevalence would be 1.36%. ‡ Misch CE, Perel ML, Wang HL, et al. Implant success, survival, and failure: the International Congress of Oral Implantologists (ICOI) Pisa Consensus Conference. I

 Open the catalog to page 1
TiUnite-2

The largest meta-analysis of a single implant brand prospective studies publications screened No cherry picking Includes all patients with a TiUnite implant prospectively evaluated in a clinical study with a minimum of 20 patients and 12 months post-loading. 99TiUnite promotes a healthy bone response during the first year which remains stable over the long term. 99Strong evidence of high implant survival with TiUnite surface. 99Low rates of reported peri-implantitis in patients with TiUnite surface implants. Karl M, Albrektsson T. Clinical performance of dental implants with a moderately rough...

 Open the catalog to page 2

All Nobel Biocare Services AG catalogs and technical brochures

  1. X-Guide

    2  Pages

  2. NobelPearl™

    8  Pages

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.